Pharma Disease Areas

Our scientists take a rigorous, comprehensive approach to understanding cancer biology and drug discovery.

With one of the strongest pipelines in the industry, Roche Neuroscience is developing medicines for a range of serious neurological diseases, including multiple sclerosis, Alzheimer’s disease, autism, spinal muscular atrophy, depression, Parkinson’s disease, Down syndrome.

Viral and bacterial infections are among the leading causes of disability and death. Roche research is committed to finding effective treatments for life-threatening infectious diseases.

We're advancing our expertise in Immunology and discovering and developing innovative medicines for patients living with severe respiratory and autoimmune diseases.

Haematology is a branch of medicine that deals with diseases of the blood. It is a complex, disparate and challenging area of medicine.

Find out more about haemophilia A and how Roche is developing novel approaches to hopefully advance the management of this serious disorder.

We are focused on saving people’s eyesight from the leading causes of vision loss through pioneering therapies.